Use of matrix cells for preparing a micro hair follicle

Patent metadata

Field	Value
Publication number	US-11530384-B2
Application number	US-201615761158-A
Country	US
Kind code	B2
Filing date	Sep 28, 2016
Priority date	Sep 29, 2015
Publication date	Dec 20, 2022
Grant date	Dec 20, 2022

Abstract

The invention relates to the use of matrix cells for obtaining a micro hair follicle and to the use thereof for evaluating the effect of cosmetic, pharmaceutical or dermatological products and also for the prophylactic or therapeutic treatment of a state of reduced pilosity.

First claim

The invention claimed is:

1. One or more micro hair follicles in the form of a bud that is obtained by means of an in vitro process comprising at least one step of culturing matrix cells which are located in the hair bulb in the presence of an effective amount of a ROCK inhibitor for a period of time sufficient to allow differentiation of said cells into keratinocytes positive for the K85 K35 markers, wherein the cells are keratinocytes positive for the K85 K35 markers and upon reaching confluence are in the form regular clusters and wherein the matrix cells are obtained from hair in the anagen phase and are free from other cell types, and wherein at least one bud comprises a structure in the form of keratinized fibre.

2. The one or more micro hair follicles according to claim 1 , in which the ROCK inhibitor is Y27632.

3. The one or more micro hair follicles according to claim 1 , in which the effective amount of the ROCK inhibitor is from 1 to 100 μM.

4. The one or more micro hair follicles according to claim 1 , in which the effective amount of the ROCK inhibitor is from 5 to 25 μM.

5. The one or more micro hair follicles according to claim 1 , in which the effective amount of the ROCK inhibitor is 10 μM.

6. The one or more micro hair follicles according to claim 1 , in which the matrix cells are cultured in the presence of the ROCK inhibitor for at least 2 days.

7. The one or more micro hair follicles according to claim 1 wherein said process comprises the following steps:
a—isolating a follicle on a support;
b—cutting, on said support immersed in a culture medium, the bulb region above the dermal papilla;
c—recovering the matrix cells in the form of a cell aggregate on said support;
d—amplifying the matrix cells in the presence of a ROCK inhibitor;
e—recovering keratinocytes positive for K35 K85 markers;
f—culturing the keratinocytes obtained in step e) in 3D culture.

8. The one or more micro hair follicles according to claim 7 , wherein in step f), the number of keratinocytes placed in culture is between 1000 and 4000 cells.

9. The one or more micro hair follicles according to claim 1 , which are constituted of cells resulting from amplification and differentiation of matrix cells which are located in the hair bulb in the presence of a ROCK inhibitor.

10. The one or more micro hair follicles according to claim 9 , wherein the ROCK inhibitor is Y27632.

11. A process for a prophylactic or therapeutic treatment of a state of reduced pilosity, which comprises implanting the one or more micro hair follicles according to claim 1 , into a subject in need of the prophylactic or therapeutic treatment of a state of reduced pilosity.

12. A process for treating alopecia which comprises implanting the one or more micro hair follicles according to claim 1 , into a subject having alopecia.

13. A process for the in vitro testing of effects of an active agent on hair properties which comprises contacting the active agent with the one or more micro hair follicles as described in claim 1 .

14. The process according to claim 13 further comprises identifying a compound which modulates the growth of body hair and/or of head hair.

15. A product screening process for the purpose of identifying novel active agents, comprising a step (a) of bringing a test product into contact with the one or more micro hair follicles according to claim 1 , then a step (b) of analyzing the effect of said product on at least one parameter of a scalp equivalent and a step (c) of selecting the product which modifies said parameter.

16. The one or more micro hair follicles according to claim 2 , in which the effective amount of the ROCK inhibitor is from 1 to 100 μM.

Assignees

• Oreal

Inventors

• Bakkar Khalid
• Collin-Djangone Christine

Classifications

• C12N2501/11

  Epidermal growth factor [EGF] · CPC title

• A61K35/36

  Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39) · CPC title

• C12N2503/02

  Drug screening · CPC title

• C12N2501/39

  Steroid hormones · CPC title

• C12N2500/30

  Organic components · CPC title